Literature DB >> 8638787

Intravenous ketorolac tromethamine worsens platelet function during knee arthroscopy under spinal anesthesia.

B K Thwaites1, D B Nigus, G W Bouska, P D Mongan, E F Ayala, G A Merrill.   

Abstract

Ketorolac prolongs bleeding time and inhibits platelet aggregation and platelet thromboxane production in healthy, awake volunteers. However, platelet function was recently shown not to worsen after ketorolac was given during general anesthesia. The purpose of this study was to investigate platelet function changes during a standardized spinal anesthetic and surgery, as well as after a single intraoperative dose of intravenous (IV) ketorolac. The study comprised 30 ASA physical status I patients undergoing spinal anesthesia for knee arthroscopy. Subjects were randomized to receive either ketorolac 60 mg IV 15 min after skin incision or placebo IV. Platelet function testing consisted of an Ivy bleeding time, platelet aggregometry with adenosine diphosphate (ADP) and collagen, thromboelastography (TEG), and serum thromboxane B2 (TxB2) assays. Platelet function testing was performed: 1) 15 min prior to the performance of spinal anesthesia; 2) 10 min after surgical skin incision; and 3) 45 min after administration of study drug. The placebo group demonstrated no changes in any platelet function variable during spinal anesthesia and surgery relative to preoperative values. The ketorolac group, however, demonstrated a significant increase in bleeding time from postincision to poststudy drug data points (213 +/- 60s to 275 +/- 85s, mean +/- SD; P < 0.01). Further, platelet aggregometry to collagen was diminished in the ketorolac group from preoperative to poststudy drug data points (90.8% +/- 7.6% to 60.5% +/- 32.5%; P < 0.01). Platelet aggregometry with ADP, however, was unchanged in the ketorolac group. Platelet TxB2 production decreased dramatically in the ketorolac group from preoperative to poststudy drug data points (157.2 +/- 129.4 to 0.3 +/- 0.3 ng/mL; P < 0.01). Platelet function does not appear to be accentuated during spinal anesthesia as it is during general anesthesia. Unlike during general anesthesia, platelet function during spinal anesthesia is impaired, with respect to bleeding time and platelet aggregometry to collagen, by a single intraoperative dose of IV ketorolac.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8638787     DOI: 10.1097/00000539-199606000-00013

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  8 in total

Review 1.  Ketorolac for postoperative pain management in children.

Authors:  J B Forrest; E L Heitlinger; S Revell
Journal:  Drug Saf       Date:  1997-05       Impact factor: 5.606

Review 2.  Minimising the adverse effects of ketorolac.

Authors:  D I Reinhart
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

3.  The effects of paracetamol, ketorolac, and paracetamol plus morphine on pain control after thyroidectomy.

Authors:  Sun Yeul Lee; Won Hyung Lee; Eun Ha Lee; Kyu Cheol Han; Young Kwon Ko
Journal:  Korean J Pain       Date:  2010-05-31

4.  Analgesic effect of intra-articular ketorolac in knee arthroscopy: comparison of morphine and bupivacaine.

Authors:  J Calmet; C Esteve; S Boada; J Giné
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2004-06-09       Impact factor: 4.342

5.  Soft tissue injections in the athlete.

Authors:  Jeffrey J Nepple; Matthew J Matava
Journal:  Sports Health       Date:  2009-09       Impact factor: 3.843

Review 6.  Influence of Ketorolac Supplementation on Pain Control for Knee Arthroscopy: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Rui-Jie Wan; Shao-Fan Liu; Zhi-Ping Kuang; Qiang Ran; Chen Zhao; Wei Huang
Journal:  Orthop Surg       Date:  2020-02       Impact factor: 2.071

7.  Intrathecal ketorolac enhances intrathecal morphine analgesia following total knee arthroplasty.

Authors:  Gabriela R Lauretti; Claudia C F Righeti; Anita L Mattos
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2013-10

8.  Platelet Function: Meloxicam Intravenous in Whole Blood Samples From Healthy Volunteers.

Authors:  Jonathan S Jahr; Shawn Searle; Stewart McCallum; Randall Mack; Kim Minger; Alex Freyer; Wei Du; Sue Hobson
Journal:  Clin Pharmacol Drug Dev       Date:  2020-01-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.